6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Non‐invasive in vivo monitoring of transplanted stem cells in 3D‐bioprinted constructs using near‐infrared fluorescent imaging

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cell‐based tissue engineering strategies have been widely established. However, the contributions of the transplanted cells within the tissue‐engineered scaffolds to the process of tissue regeneration remain poorly understood. Near‐infrared (NIR) fluorescence imaging systems have great potential to non‐invasively monitor the transplanted cell‐based tissue constructs. In this study, labeling mesenchymal stem cells (MSCs) using a lipophilic pentamethine indocyanine (CTNF127, emission at 700 nm) as a NIR fluorophore was optimized, and the CTNF127‐labeled MSCs (NIR‐MSCs) were printed embedding in gelatin methacryloyl bioink. The NIR‐MSCs‐loaded bioink showed excellent printability. In addition, NIR‐MSCs in the 3D constructs showed high cell viability and signal stability for an extended period in vitro. Finally, we were able to non‐invasively monitor the NIR‐MSCs in constructs after implantation in a rat calvarial bone defect model, and the transplanted cells contributed to tissue formation without specific staining. This NIR‐based imaging system for non‐invasive cell monitoring in vivo could play an active role in validating the cell fate in cell‐based tissue engineering applications.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: not found

          Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels.

          Gelatin methacryloyl (GelMA) hydrogels have been widely used for various biomedical applications due to their suitable biological properties and tunable physical characteristics. GelMA hydrogels closely resemble some essential properties of native extracellular matrix (ECM) due to the presence of cell-attaching and matrix metalloproteinase responsive peptide motifs, which allow cells to proliferate and spread in GelMA-based scaffolds. GelMA is also versatile from a processing perspective. It crosslinks when exposed to light irradiation to form hydrogels with tunable mechanical properties. It can also be microfabricated using different methodologies including micromolding, photomasking, bioprinting, self-assembly, and microfluidic techniques to generate constructs with controlled architectures. Hybrid hydrogel systems can also be formed by mixing GelMA with nanoparticles such as carbon nanotubes and graphene oxide, and other polymers to form networks with desired combined properties and characteristics for specific biological applications. Recent research has demonstrated the proficiency of GelMA-based hydrogels in a wide range of tissue engineering applications including engineering of bone, cartilage, cardiac, and vascular tissues, among others. Other applications of GelMA hydrogels, besides tissue engineering, include fundamental cell research, cell signaling, drug and gene delivery, and bio-sensing.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gelatin-Methacryloyl Hydrogels: Towards Biofabrication-Based Tissue Repair.

            Research over the past decade on the cell-biomaterial interface has shifted to the third dimension. Besides mimicking the native extracellular environment by 3D cell culture, hydrogels offer the possibility to generate well-defined 3D biofabricated tissue analogs. In this context, gelatin-methacryloyl (gelMA) hydrogels have recently gained increased attention. This interest is sparked by the combination of the inherent bioactivity of gelatin and the physicochemical tailorability of photo-crosslinkable hydrogels. GelMA is a versatile matrix that can be used to engineer tissue analogs ranging from vasculature to cartilage and bone. Convergence of biological and biofabrication approaches is necessary to progress from merely proving cell functionality or construct shape fidelity towards regenerating tissues. GelMA has a critical pioneering role in this process and could be used to accelerate the development of clinically relevant applications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing

              Although three-dimensional (3D) bioprinting technology has gained much attention in the field of tissue engineering, there are still several significant engineering challenges to overcome, including lack of bioink with biocompatibility and printability. Here, we show a bioink created from silk fibroin (SF) for digital light processing (DLP) 3D bioprinting in tissue engineering applications. The SF-based bioink (Sil-MA) was produced by a methacrylation process using glycidyl methacrylate (GMA) during the fabrication of SF solution. The mechanical and rheological properties of Sil-MA hydrogel proved to be outstanding in experimental testing and can be modulated by varying the Sil-MA contents. This Sil-MA bioink allowed us to build highly complex organ structures, including the heart, vessel, brain, trachea and ear with excellent structural stability and reliable biocompatibility. Sil-MA bioink is well-suited for use in DLP printing process and could be applied to tissue and organ engineering depending on the specific biological requirements.
                Bookmark

                Author and article information

                Contributors
                hlpch@hallym.ac.kr
                sjlee@wakehealth.edu
                Journal
                Bioeng Transl Med
                Bioeng Transl Med
                10.1002/(ISSN)2380-6761
                BTM2
                Bioengineering & Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2380-6761
                26 March 2021
                May 2021
                : 6
                : 2 ( doiID: 10.1002/btm2.v6.2 )
                : e10216
                Affiliations
                [ 1 ] Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard Winston‐Salem North Carolina USA
                [ 2 ] Nano‐Bio Regenerative Medical Institute, College of Medicine, Hallym University Chuncheon Republic of Korea
                [ 3 ] Department of Molecular Science and Technology Ajou University Suwon Republic of Korea
                [ 4 ] Department of Otolaryngology‐Head and Neck Surgery Korea University College of Medicine Seoul Republic of Korea
                [ 5 ] Gordon Center for Medical Imaging, Department of Radiology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA
                [ 6 ] Department of Otorhinolaryngology‐Head and Neck Surgery Chuncheon Sacred Heart Hospital, School of Medicine, Hallym University Chuncheon Republic of Korea
                Author notes
                [*] [* ] Correspondence

                Chan Hum Park, Department of Otorhinolaryngology‐Head and Neck Surgery, Chuncheon Sacred Heart Hospital, School of Medicine, Hallym University, Chuncheon 24252, Republic of Korea.

                Email: hlpch@ 123456hallym.ac.kr

                Sang Jin Lee, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston‐Salem, NC 27157, USA.

                Email: sjlee@ 123456wakehealth.edu

                Author information
                https://orcid.org/0000-0002-7587-9414
                https://orcid.org/0000-0002-7982-6483
                https://orcid.org/0000-0002-9732-361X
                https://orcid.org/0000-0002-3899-1909
                Article
                BTM210216
                10.1002/btm2.10216
                8126817
                34027098
                62eac9ff-03bb-46e9-8f30-cf81e2010461
                © 2021 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 February 2021
                : 10 September 2020
                : 01 March 2021
                Page count
                Figures: 6, Tables: 2, Pages: 13, Words: 8880
                Funding
                Funded by: Hallym University , open-funder-registry 10.13039/501100002632;
                Award ID: Hallym University Research Fund
                Funded by: Ministry of Science, ICT and Future Planning , open-funder-registry 10.13039/501100003621;
                Award ID: NRF‐2020R1A2C3010040
                Funded by: National Institutes of Health , open-funder-registry 10.13039/100000002;
                Award ID: P41EB023833
                Award ID: R01EB022230
                Award ID: R01HL143020
                Categories
                Research Report
                Research Reports
                Custom metadata
                2.0
                May 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.2 mode:remove_FC converted:17.05.2021

                near‐infrared fluorescence,non‐invasive monitoring,scaffold monitoring,stem cell tracking

                Comments

                Comment on this article